13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-11, with 52 holding rows worth $363,789,000.
- Accession
- 0001420506-21-001028
- Filer
- CIK 1595851
- Filed
- 2021-08-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 52 entries on the cover page, a total value of $363,789,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $363,789,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $40,620,000 | thousands by filing date | call |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 570,000 | $18,120,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 135,000 | $17,759,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 185,000 | $16,056,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 850,000 | $15,827,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 205,000 | $15,785,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 875,000 | $15,024,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 700,000 | $14,595,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,600,000 | $12,976,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 1,250,000 | $12,125,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 450,000 | $11,709,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 32,500 | $11,254,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 285,000 | $9,530,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 50,000 | $8,077,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 275,000 | $7,172,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 180,000 | $6,982,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 600,000 | $6,798,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,000,000 | $6,540,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 350,000 | $6,402,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 904,225 | $6,375,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 2,000,000 | $6,300,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 450,000 | $6,111,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 200,000 | $6,072,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 207,500 | $5,928,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 125,000 | $5,536,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 500,000 | $5,175,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 75,000 | $5,167,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 170,000 | $4,927,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 243,309 | $4,586,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 725,000 | $4,575,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 250,000 | $4,390,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 1,000,000 | $4,330,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 1,600,000 | $4,000,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 200,000 | $3,894,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 125,000 | $3,529,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 145,000 | $3,264,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 265,000 | $3,249,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 800,000 | $3,096,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 265,000 | $2,555,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 200,000 | $2,114,000 | thousands by filing date | call |
| CURIS INC | 231269200 | COM | 247,124 | $1,994,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 75,000 | $1,922,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 200,000 | $1,600,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 75,000 | $1,580,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 100,000 | $1,357,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 150,000 | $1,265,000 | thousands by filing date | put |
| CASI PHARMACEUTICALS INC | 14757U109 | COM | 650,000 | $1,008,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 450,000 | $1,004,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 100,000 | $982,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 4,000 | $940,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 100,000 | $843,000 | thousands by filing date | |
| CODEX DNA INC | 192003101 | COM | 35,000 | $770,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-21-001028 | this filing | 2021-08-11 | acceptance time not in the bulk data set |